BridgeMD
Antibiotic pharmacokinetics in women with twin pregnancy
EU CTIS ID: 2024-518564-12-00
What this study is testing
Determine the antibiotic concentration in maternal blood and newborn blood (from the umbilical cord) and investigate the potential difference in antibiotic concentration between twin siblings.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Women with twin pregnancies and delivery through c-section between 24- 42 gestational weeks
- Receiving one or more of the included antibiotic agents
- Able and willing to sign the consent
- Ages 18-55 years old
You likely can't join if
- Any medical condition that, in the opinion of the Investigator or research team member, could potentially interfere with the study objectives
- Patients who are not willing to sign the consent
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.